Coinbase Stock Stalls $200 After 14% Rally, Traders Pause
Coinbase stock stalls $200 after a 14% surge, with traders watching volume and regulatory headlines for the next move...
Which Is Better Stock Index Or Index Fund
Choosing between a stock index and an index fund depends on costs, flexibility, and your investment objectives. This article compares the options clearly.
25,679 articles
This Stock’s Downgrade Shows War Costs Hit Markets
Geopolitical frictions with Iran are boosting energy and raw-material costs. A prominent downgrade underscores how th...
Warby Parker Director Dumped: What Investors Should Know Now
A Warby Parker director recently sold 25,000 shares, triggering questions about insider moves. This article breaks do...
Credo Stock Opens Door for Bulls as Dip Attracts Buyers
Credo Technology posted a strong Q3 with revenue growth and new TAM expansions, even as margins face near-term pressu...
Klaviyo Director Sold Over 9,000 Shares: Investor Insight
When a Klaviyo director sold over 9,000 shares, it sparked questions about timing, risk, and company confidence. This...
Mark Your Calendar: NuScale Stock Could Soar Soon This Fall
As AI fuels energy needs, NuScale’s small modular reactors offer a faster, scalable path to cleaner power. This guide...
This Chip Design Stock Stays Below Peak as Revenue Rises
Synopsys, a leader in chip design software, trades below its 52-week high even as revenue grows, highlighting investo...
Here's Strongly Considering Selling XRP: A Cautious Take
After a year of catalyst-driven hopes, XRP’s price hasn’t followed suit. This article lays out a practical framework ...
Chip Pullback Ushering Bumpy Market Prompts Sector Bets
Morgan Stanley argues that a selective rotation is underway as the chip pullback ushering bumpy market reshapes leade...
Nasdaq's Rough Day: When Good News Backfires for Markets
On days when upbeat earnings flood the headlines, the Nasdaq sometimes slips instead of rallying. This article explai...
Lantheus (LNTH) 2025 Earnings Outlook: PET Diagnostics Pivot
Lantheus is steering a strategic shift toward PET radiodiagnostics, aiming to unlock new growth. This article breaks ...
Forget Oral Wegovy: This Could Be a Bigger Win for Investors
The launch of oral Wegovy marked a turning point for weight-loss drugs and stock investors. But a newer, rival oral G...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status